Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) Peer Comparison
$17.83
$0.00 (0.00%)As on 14-Mar-2024 09:30EDT
Market cap
$-- Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 5,305 | 3,392 | 778 | 449 |
Revenue ($ Mln) |
-- | 440 | 2,883 | -- | 330 |
Net Profit ($ Mln) |
1.24 | -1,435.01 | -118.30 | -134.20 | 100.20 |
Net Margin (%) |
-- | -325.91 | -4.10 | -- | 30.33 |
RoE (%) |
0.65 | -- | -- | -40.17 | 30.44 |
Price to Earnings |
-- | -- | -- | -- | 4.68 |
Price-To-Book |
-- | -- | 1.35 | -- | 1.31 |
Income Statement ($ Mln)
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 502.40 | 2,986.40 | -- | 263.68 |
|
Cost of Revenue
|
-- | 378.94 | 1,886.10 | -- | 122.11 |
|
Gross Profit
|
-- | 123.46 | 1,100.30 | -- | 141.56 |
|
Operating Expenses
|
6.33 | 114.50 | 960.60 | -- | 45.48 |
|
Operating Profit (EBIT)
|
-6.33 | 8.96 | 139.70 | -- | 96.08 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
3.00 | -245.80 | -72.70 | -- | 96.08 |
|
Provision for Tax
|
1.76 | 0.68 | 34.20 | -- | 10.88 |
|
Profit after Tax (Net Income)
|
1.24 | -246.49 | -93.50 | -- | 309.91 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
99.15 | -596.94 | -1,152.40 | -- | 168.77 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
6.04 | 820.67 | 2,487.60 | -- | 373.89 |
|
Current Liabilities
|
9.51 | 488.42 | 3,642.30 | -- | 75.60 |
|
Total Liabilities
|
114.70 | 712.16 | 5,103.00 | -- | 1,060.38 |
Assets ($ Mln)
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
114.64 | 615.14 | 3,730.90 | -- | 344.28 |
|
Current Assets
|
0.06 | 97.02 | 1,372.10 | -- | 153.76 |
|
Total Assets
|
114.70 | 712.16 | 5,103.00 | -- | 1,060.38 |
|
Total Debt*
|
-- | 865.55 | 3,721.30 | -- | 149.46 |
|
Net Current Assets
|
-9.45 | -391.41 | -2,270.20 | -- | -- |
Cashflow ($ Mln)
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.98 | 65.11 | 488.90 | -- | -136.00 |
|
Cash Flow from Investing Activities
|
-- | -3.00 | -331.80 | -- | -2.54 |
|
Cash from Financing Activities
|
-188.13 | -44.65 | -74.90 | -- | 26.77 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
0.65 | 350.27 | -3.76 | -- | 211.82 |
|
ROE (%)
|
0.65 | 48.99 | 9.68 | -- | -5,428.46 |
|
ROA (%)
|
0.61 | -32.44 | -1.97 | -- | 15.89 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -49.06 | -3.13 | -- | 117.53 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -0.22 | -0.03 | -- | 0.19 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-39.13 | 88.52 | -31,066.67 | -- | 165.96 |
|
EPS Growth (%)
|
0.23 | 0.89 | -162.41 | -- | 1.62 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
153.19 | -- | -- | -- | 1.40 |
|
Price / Book Value
|
1.92 | -- | -- | -- | 2.56 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-30.07 | -- | -- | -- | 3.71 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | -1.45 | -3.23 | -- | 0.89 |
|
Short term debt to equity ratio
|
-- | -0.24 | -1.96 | -- | 0.00 |
|
Current Ratio
|
0.01 | 0.20 | 0.38 | -- | 2.03 |
|
Quick Ratio
|
-- | 0.21 | 0.39 | -- | 11.60 |
|
Interest Coverage
|
-- | -1.85 | 1.38 | -- | 9.83 |
Operating Efficiency Ratios
| Power & Digital Infrastructure Acquisition II Corp Unit (XPDBU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Atlas Crest Investment Corp (ACIC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 1.42 | 32.85 | -- | 146.67 |
|
Asset Turnover
|
0.00 | 0.66 | 0.63 | -- | 0.14 |
|
Receivable days
|
-- | 2.70 | 113.66 | -- | 1,457.99 |
|
Inventory Days
|
-- | -5.94 | -0.78 | -- | -1,670.28 |
|
Payable days
|
-- | 100.43 | 48.20 | -- | 314.06 |
|
Cash Conversion Cycle
|
-- | -103.67 | 64.67 | -- | -526.35 |